# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-23-110602
Filing Date
2023-10-23
Accepted
2023-10-20 21:46:19
Documents
165

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM S-1/A | aeon-20230630xs1a.htm iXBRL | S-1/A | 7348323
2 | EXHIBIT 5.1 | aeon-20230630xex5d1.htm | EX-5.1 | 31890
3 | EXHIBIT 23.1 | aeon-20230630xex23d1.htm | EX-23.1 | 2636
4 | EXHIBIT 23.2 | aeon-20230630xex23d2.htm | EX-23.2 | 2787
5 | EXHIBIT-FILING FEES | aeon-20230630xexfilingfees.htm | EX-FILING FEES | 102055
11 | GRAPHIC | aeon-20230630xex5d1001.jpg | GRAPHIC | 6107
12 | GRAPHIC | aeon-20230630xex5d1002.jpg | GRAPHIC | 3959
13 | GRAPHIC | aeon-20230630xs1a009.jpg | GRAPHIC | 11902
14 | GRAPHIC | aeon-20230630xs1a014.jpg | GRAPHIC | 55116
| Complete submission text file | 0001104659-23-110602.txt |  | 25422083

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | aeon-20230630.xsd | EX-101.SCH | 143273
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | aeon-20230630_cal.xml | EX-101.CAL | 91994
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | aeon-20230630_def.xml | EX-101.DEF | 866859
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | aeon-20230630_lab.xml | EX-101.LAB | 888690
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | aeon-20230630_pre.xml | EX-101.PRE | 1231347
158 | EXTRACTED XBRL INSTANCE DOCUMENT | aeon-20230630xs1a_htm.xml | XML | 3715267

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-274094 | Film No.: 231338368
SIC: 2834 Pharmaceutical Preparations